Alerts will be sent to your verified email
Verify Email
VISTAPH
|
Vista Pharma
|
JFL Life Sciences
|
Vivo Bio Tech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-9.45 % | 11.5 % | 8.25 % |
|
5yr average Equity Multiplier
|
1.52 | 3.23 | 2.25 |
|
5yr Average Asset Turnover Ratio
|
0.14 | 0.95 | 0.54 |
|
5yr Avg Net Profit Margin
|
-199.64 % | 4.98 % | 6.78 % |
|
Price to Book
|
1.2 | 0.0 | 1.05 |
|
P/E
|
0.0 | 17.71 | 9.0 |
|
5yr Avg Cash Conversion Cycle
|
397.29 Days | 217.93 Days | 69.38 Days |
|
Inventory Days
|
3019.63 Days | 85.64 Days | 71.5 Days |
|
Days Receivable
|
452.93 Days | 186.74 Days | 97.07 Days |
|
Days Payable
|
1804.78 Days | 98.82 Days | 108.42 Days |
|
5yr Average Interest Coverage Ratio
|
-2.3 | 3.02 | 2.17 |
|
5yr Avg ROCE
|
-7.56 % | 18.94 % | 14.55 % |
|
5yr Avg Operating Profit Margin
|
-188.68 % | 9.53 % | 35.36 % |
|
5 yr average Debt to Equity
|
0.33 | 1.19 | 1.09 |
|
5yr CAGR Net Profit
|
4.15 % | 55.85 % | -10.64 % |
|
5yr Average Return on Assets
|
-6.28 % | 4.15 % | 4.02 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
21.19 % | 67.47 % | 40.85 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.25 % | 0.0 | 1.18 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.02 % | 0.0 | 0.0 |
|
Vista Pharma
|
JFL Life Sciences
|
Vivo Bio Tech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|